GleamWall
中文EN

TXG 10x Genomics, Inc.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1770787 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.6%
TTM net income YoY12.1%
TTM EPS YoY17.5%
Revenue 3-yr CAGR1.5%
Net income 3-yr CAGR—

Margins

Gross margin71.9%
Operating margin-11.7%
Net margin-10.8%
FCF margin15.2%
EBITDA margin-5.3%

Returns

ROE-8.3%
ROA-6.4%
ROIC (approx.)-17.2%
Asset turnover0.59x

Leverage & solvency

Liabilities / assets21.2%
Debt / equity0.00x
Current ratio5.12x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-1.49x
Accruals ratio-16.0%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$642.82M$610.78M
Cost of revenue$198.94M$196.30M
Gross profit$443.88M$414.48M
R&D expense$238.63M$264.70M
SG&A expense$316.13M$344.34M
Operating income-$60.98M-$194.56M
Interest expense$0$4,000
Pretax income-$39.91M-$177.70M
Income tax$3.64M$4.93M
Net income-$43.54M-$182.63M
EBITDA-$24.79M-$158.68M
EPS (basic)-0.35-1.52
EPS (diluted)-0.35-1.52
Weighted avg. shares (diluted)124.75M120.45M
Balance sheet
Cash & equivalents$473.97M$344.07M
Short-term investments$49.44M$49.34M
Receivables$47.01M$87.86M
Inventory$56.34M$83.11M
Current assets$684.45M$584.39M
PP&E, net$226.71M$252.65M
Goodwill$4.51M$4.51M
Intangibles$62.33M$15.67M
Total assets$1.04B$918.64M
Current liabilities$153.45M$117.63M
Total liabilities$245.04M$208.50M
Shareholders' equity$796.33M$710.13M
Shares outstanding127.69M122.29M
Cash flow statement
Operating cash flow$136.05M$6.66M
Capital expenditure$5.93M$12.39M
Free cash flow$130.12M-$5.73M
Investing cash flow-$13.44M-$32.63M
Financing cash flow$6.80M$10.91M
Depreciation & amortization$36.20M$35.88M
Stock-based compensation$109.12M$140.75M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.